Sanofi-Aventis S.A. ADR (NQ: SNY )
48.62
-1.49
(-2.97%)
Streaming Delayed Price
Updated: 10:26 AM EDT, Jun 26, 2024
Add to My Watchlist
Headline News about Sanofi-Aventis S.A. ADR![]()
Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger
September 19, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]()
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
September 08, 2022
Via Benzinga
![]()
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
Via Benzinga
![]() ![]()
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Via Benzinga
![]()
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
August 30, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|